These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 18072075
1. Relationship between endogenous parathyroid hormone and bone metabolism/geometry in female patients treated with glucocorticoid. Kaji H, Yamauchi M, Chihara K, Sugimoto T. Horm Metab Res; 2008 Jan; 40(1):60-5. PubMed ID: 18072075 [Abstract] [Full Text] [Related]
2. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys. Fox J, Miller MA, Newman MK, Recker RR, Turner CH, Smith SY. Bone; 2007 Sep; 41(3):321-30. PubMed ID: 17573250 [Abstract] [Full Text] [Related]
3. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y. Life Sci; 2005 Jul 22; 77(10):1130-9. PubMed ID: 15978265 [Abstract] [Full Text] [Related]
4. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur. Fox J, Miller MA, Recker RR, Turner CH, Smith SY. Calcif Tissue Int; 2007 Jul 22; 81(1):53-63. PubMed ID: 17551766 [Abstract] [Full Text] [Related]
5. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment. Oxlund H, Ortoft G, Thomsen JS, Danielsen CC, Ejersted C, Andreassen TT. Bone; 2006 Aug 22; 39(2):244-52. PubMed ID: 16503210 [Abstract] [Full Text] [Related]
6. [Glucocorticoids and osteoporosis]. Zikán V. Vnitr Lek; 2007 Aug 22; 53(7-8):831-40. PubMed ID: 17915428 [Abstract] [Full Text] [Related]
7. Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. Chen Q, Kaji H, Iu MF, Nomura R, Sowa H, Yamauchi M, Tsukamoto T, Sugimoto T, Chihara K. J Clin Endocrinol Metab; 2003 Oct 22; 88(10):4655-8. PubMed ID: 14557436 [Abstract] [Full Text] [Related]
8. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84. Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, Fox J. Bone; 2009 Jan 22; 44(1):113-9. PubMed ID: 18983947 [Abstract] [Full Text] [Related]
9. Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone. Sosa M, Jódar E, Saavedra P, Navarro MC, Gómez de Tejada MJ, Martín A, Peña P, Gómez J. Eur J Intern Med; 2008 Jan 22; 19(1):51-6. PubMed ID: 18206602 [Abstract] [Full Text] [Related]
10. Low density lipoprotein-cholesterol levels affect vertebral fracture risk in female patients with primary hyperparathyroidism. Kaji H, Hisa I, Inoue Y, Sugimoto T. Exp Clin Endocrinol Diabetes; 2010 Jun 22; 118(6):371-6. PubMed ID: 19609845 [Abstract] [Full Text] [Related]
11. The usefulness of bone metabolic indices for the prediction of changes in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism. Kaji H, Nomura R, Yamauchi M, Chihara K, Sugimoto T. Horm Metab Res; 2006 Jun 22; 38(6):411-6. PubMed ID: 16823724 [Abstract] [Full Text] [Related]
12. Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects. Paz-Pacheco E, Fuleihan GE, LeBoff MS. J Bone Miner Res; 1995 Nov 22; 10(11):1713-8. PubMed ID: 8592948 [Abstract] [Full Text] [Related]
13. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Cejka D, Jäger-Lansky A, Kieweg H, Weber M, Bieglmayer C, Haider DG, Diarra D, Patsch JM, Kainberger F, Bohle B, Haas M. Nephrol Dial Transplant; 2012 Jan 22; 27(1):226-30. PubMed ID: 21613383 [Abstract] [Full Text] [Related]
14. Severe cortical and trabecular osteopenia in secondary hyperparathyroidism. Brancaccio D, Di Leo C, Bestetti A, Carpani P, Tagliabue L, Cozzolino M, Galassi A, Luigi Tarolo G, Gallieni M. Hemodial Int; 2003 Apr 01; 7(2):122-9. PubMed ID: 19379351 [Abstract] [Full Text] [Related]
15. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures. Tuck SP, Scane AC, Fraser WD, Diver MJ, Eastell R, Francis RM. Bone; 2008 Dec 01; 43(6):999-1005. PubMed ID: 18817902 [Abstract] [Full Text] [Related]
16. Parathyroid hormone secretion in women in late menopause submitted to EDTA-induced hypocalcemia. Pereira LC, Pereira FA, Sá MF, Foss MC, de Paula FJ. Maturitas; 2008 Jan 20; 59(1):91-4. PubMed ID: 18037250 [Abstract] [Full Text] [Related]
17. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1. Bodine PV, Seestaller-Wehr L, Kharode YP, Bex FJ, Komm BS. J Cell Physiol; 2007 Feb 20; 210(2):352-7. PubMed ID: 17044082 [Abstract] [Full Text] [Related]
18. [A clinical study of abnormal bone metabolism in patients with HBV liver cirrhosis]. Wang YG, Liu Q, Wang WQ, Chen ZP, Yan MX. Zhonghua Gan Zang Bing Za Zhi; 2006 Jan 20; 14(1):33-6. PubMed ID: 16420762 [Abstract] [Full Text] [Related]
19. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease. Heijckmann AC, Huijberts MS, Schoon EJ, Geusens P, de Vries J, Menheere PP, van der Veer E, Wolffenbuttel BH, Stockbrugger RW, Dumitrescu B, Nieuwenhuijzen Kruseman AC. Eur J Gastroenterol Hepatol; 2008 Aug 20; 20(8):740-7. PubMed ID: 18617778 [Abstract] [Full Text] [Related]
20. Glucocorticosteroid-induced osteoporosis in adult primiparous Göttingen miniature pigs: effects on bone mineral and mineral metabolism. Scholz-Ahrens KE, Delling G, Stampa B, Helfenstein A, Hahne HJ, Açil Y, Timm W, Barkmann R, Hassenpflug J, Schrezenmeir J, Glüer CC. Am J Physiol Endocrinol Metab; 2007 Jul 20; 293(1):E385-95. PubMed ID: 17456640 [Abstract] [Full Text] [Related] Page: [Next] [New Search]